Working… Menu

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer (CIK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01631357
Recruitment Status : Completed
First Posted : June 29, 2012
Last Update Posted : November 5, 2019
Information provided by (Responsible Party):
Tianjin Medical University Cancer Institute and Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2018
Actual Study Completion Date : December 2018